FindTrial
Sign In

Efficacy and acceptability of interval fasting in cardiac rehabilitation - a randomized controlled trial

Efficacy and acceptability of interval fasting in cardiac rehabilitation - a randomized controlled trial - InterVfast

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00023983
Enrollment
100
Registered
2022-02-17
Start date
2022-03-15
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I20-I25 E65-E68

Interventions

Group 1: The intervention group completes an interval fasting program during rehabilitation (four weeks). The fasting time is individually adapted to the needs of the participants (the target interval

Sponsors

refonet Rehabilitations-Forschungsnetzwerk der Deutschen Rentenversicherung Rheinland
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: BMI between 28 and 35 kg/m2

Exclusion criteria

Exclusion criteria: Excludes patients with addictive disorders, eating disorders, liver cirrhosis, renal insufficiency grade 4 or higher, severe obesity (BMI > 35 kg/m2), oncologic diseases, gastric/duodenal ulcers, or language impairment.

Design outcomes

Primary

MeasureTime frame
Change in weight relative to baseline weight during four weeks of inpatient rehabilitation.—

Secondary

MeasureTime frame
Changes in waist-to-hip ratio, body fat percentage, cholesterol, triglycerides, blood pressure, blood glucose, HOMA index, GGT, CRP during four weeks of rehabilitation compared to control group.—

Countries

Germany

Contacts

Public ContactWolfgang Mayer-Berger

Klinik Roderbirken

Wolfgang.Mayer-Berger@klinik-roderbirken.de02175/82-4010

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 7, 2026